期刊文献+

SRT2104对小鼠糖尿病肾病发病机制及SIRT1/P53/NRF2通路的影响 被引量:8

Effect of SRT2104 on pathogenesis of diabetic nephropathy and the SIRT1/P53/NRF2 pathway
下载PDF
导出
摘要 目的研究SRT2104对糖尿病肾病(DN)小鼠肾功能、肾纤维化、肾炎症及肾氧化应激的影响,并探讨其影响机制。方法将36只雄性BABL/c小鼠随机均分为3组:对照组、DN组和DN+S组,后两组小鼠通过连续5 d腹腔注射50 mg/kg的链脲佐菌素建立DN小鼠模型,之后DN+S组小鼠给予含有SRT2104的饮食喂养24周。最后检测各组小鼠的血糖及肾功能指标,以及肾皮质中肾纤维化、肾炎症及肾氧化应激相关指标和SIRT1/P53/NRF2通路分子的水平。结果DN组和DN+S组的血糖均高于对照组(P<0.05),但DN组和DN+S组组间对比无显著差异。DN组小鼠的尿白蛋白和尿肌酐的比率(UACR)、肾重量/胫骨长度、尿素氮(BUN)、血肌酐(SCr)和血β2-微球蛋白(β2-MG)的数值均显著高于对照组(P<0.05),DN+S组显著低于DN组(P<0.05)。DN组小鼠肾皮质中纤维化指标转化生长因子β1(TGF-β1)和结缔组织生长因子(CTGF)的表达、炎症指标纤溶酶原激活剂抑制剂-1(PAI-1)和VCAM-1的表达和氧化应激指标诱导型一氧化氮合酶(iNOS)、活性氧(ROS)和丙二醛(MDA)的水平均显著高于对照组(P<0.05),DN+S组显著低于DN组(P<0.05)。DN+S小鼠肾皮质中SIRT1和NRF2的表达均显著高于DN组(P<0.05),P53乙酰化程度低于DN组(P<0.05)。结论SRT2104可降低DN小鼠肾纤维化、肾炎症及肾氧化应激,改善肾损伤,其机制与SIRT1/P53/NRF-2通路的激活有关。 Objective To investigate the effects of SRT2104 on renal function,renal fibrosis,renal inflammation and renal oxidative stress in diabetic nephropathy(DN)mice,and intend to explore its mechanism.Methods 36 male BABL/c mice were randomly divided into 3 groups,including control group,DN group and DN+S group.The mice in latter two groups were intraperitoneal injected 50 mg/kg streptozotocin for 5 consecutive days to establish DN mice model.Then mice in the DN+S group were fed with a diet containing SRT2104 for 24 weeks.Finally,levels of indexes of blood glucose and renal function,levels of renal fibrosis,renal inflammation and renal oxidative stress related indicators,and expressions of SIRT1/P53/NRF2 pathway molecules were measured.Results The blood glucose levels in the DN group and the DN+S group were higher than those in the control group(P<0.05),but there was no significant difference between the two groups.The ratio of urinary albumin to urinary creatinine(UACR),kidney weight/tibia length,BUN,SCr andβ2-MG in the DN group were significantly higher than those in the control group(P<0.05),those in DN+S group significantly lower than the DN group(P<0.05).The expressions of renal fibrosis indicators TGF-β1 and CTGF,the expression of inflammatory markers PAI-1 and VCAM-1,and the levels of oxidative stress indicators iNOS,ROS and MDA of the renal cortex in the DN group were significantly higher than those of the control group(P<0.05),those in the DN+S group were significantly lower than the DN group(P<0.05).The expressions of SIRT1 and NRF2 in the renal cortex of DN+S mice were significantly higher than those in the DN group(P<0.05),and the degree of P53 acetylation was lower than that in the DN group(P<0.05).Conclusion SRT2104 can reduce renal fibrosis,renal inflammation and renal oxidative stress in DN mice,and improve renal injury.The mechanism maybe related to the activation of SIRT1/P53/NRF-2 pathway.
作者 郑海瑞 贾卫国 王国强 王素平 ZHENG Hai-rui;JIA Wei-guo;WANG Guo-qiang(Department of Nephrology,Inner Mongolia Baogang Hospital,Baotou Inner Mongolia 014010,China)
出处 《临床和实验医学杂志》 2019年第16期1713-1716,共4页 Journal of Clinical and Experimental Medicine
基金 内蒙古自然科学基金(编号:2016MS0811)
关键词 小鼠 糖尿病肾病 SRT2104 SIRT1/P53/NRF2 机制 Mice Diabetic nephropathy SRT2104 SIRT1/P53/NRF2 Mechanism
  • 相关文献

参考文献7

二级参考文献101

  • 1朱辟疆.细胞外基质与肾小球硬化[J].中国中西医结合肾病杂志,2000,1(2):123-125. 被引量:40
  • 2Nangaku M. Mechanisms of tubulointerstitial injury in the kindney:final common pathways to end-stage renal failure [ J ]. Intern Med, 2004,43 ( 1 ) :9 - 17.
  • 3Razzaque MS, Taguchi L. Cellular and molecular events leading to renal mbulointerstifial fibrosis [ J ]. Med Electron Microse, 2002, 35 (2) :68 -80.
  • 4Zhang G, Kim H, Cai X, et al. Urokinase receptor deficiency accelerates renal fibrosis in obstructive nephropathy [ J ]. J Am Soc Nephrol,2003, 14(5) :1254 - 1271.
  • 5Hertig A, Berrou J, Anory Y, et al. Type I plasminogen activator inhibitor deficiency aggravates the course of experimental glomerulonephritis through overaetivafion of transforming growth factor beta [ J ]. FASEB J, 2003,17 ( 13 ) : 1904 - 1906.
  • 6Eddy AA. Plasminogen activator inhibitor-1 and the kidney [ J ]. Am J Physiol Renal Physiol, 2002, 283 (2) : F209 - 220.
  • 7Pontrelli P, Ranier E, Ursi M, et al. Jun-N-terminal kinas regulatesthrombin- induced PAId gene expression in proximal tubular epithelial cells[J]. Kidney Int, 2004,65(6) :2249 -2261.
  • 8Lassila M, Fukami K, Jandeleit-Dahm K, et al. Plasminogen activator inhibitor-1 production is pathogenetic in experimental routine diabetic renal disease [J]. Diabetologia,2007,50(6) :1315 - 1326.
  • 9He L, Qi Y, Rong X, et al. The ayurvedic medicine salaeia oblonga attenuates diabetic renal fibrosis in rats : suppression of angiotensin II / AT-1 signaling[J]. Evid Based Complement Altemat Med, 2009,25 [ Epub ahead of print].
  • 10Samarakoon R, Higgins CE, Higgins SP, ct al. TGF-betal-Induced Expression of the Poor Prognosis SERPINE1/PAI-1 Gene Requires EGFR Signaling: A New Target for Anti-EGFR Therapy[J]. J Oncol,2009, 9:342-391.

共引文献118

同被引文献61

引证文献8

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部